Cidara Therapeutics
CDTX
CDTX
48 hedge funds and large institutions have $102M invested in Cidara Therapeutics in 2017 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 16 increasing their positions, 9 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
13% more capital invested
Capital invested by funds: $90M → $102M (+$11.5M)
0.36% more ownership
Funds ownership: 3.33% → 3.69% (+0.36%)
Holders
48
Holding in Top 10
5
Calls
–
Puts
–
Top Buyers
| 1 | +$6.53M | |
| 2 | +$5.44M | |
| 3 | +$1.87M | |
| 4 |
ACM
Alethea Capital Management
Mercer Island,
Washington
|
+$355K |
| 5 |
Renaissance Technologies
New York
|
+$253K |
Top Sellers
| 1 | -$672K | |
| 2 | -$626K | |
| 3 | -$521K | |
| 4 |
ARTA
A.R.T. Advisors
New York
|
-$231K |
| 5 |
Squarepoint
New York
|
-$167K |